作为免疫相关不良事件的预测因素的T细胞耐受分数
Jared Ostmeyer1, Jason Y Park2, Mitchell S von Itzstein3
1Peter O'Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Journal for immunotherapy of cancer
|August 14, 2023
概括
一种新的T细胞耐受性分量指标可以预测接受免疫检查点抑制剂 (ICI) 治疗的患者的严重免疫相关不良事件 (irAEs). 这一发现为管理ICI诱导的毒性提供了潜在的生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 免疫检查点抑制剂 (ICI) 疗法可能导致严重的自身免疫副作用,称为免疫相关不良事件 (irAEs).
- 在ICI疗效和毒性方面,T细胞起着至关重要的作用,这表明T细胞分析可以预测irAE风险.
研究的目的:
- 评估一种新型指标,即T细胞耐受性分数,作为接受ICI治疗的患者未来irAEs的预测指标.
- 为了比较T细胞耐受性分数与传统的T细胞受体β (TRB) 克隆性和多样性指标的预测性能.
主要方法:
- 在接受ICI治疗的77名癌症患者的基线预治疗样本上进行了T细胞受体β (TRB) 位测序.
- 计算T细胞耐受性分数并评估其预测临床显著irrAEs的能力 (CTCAE等级≥2vs0-1).
- 耐受性分数进一步分析了针对自身抗原napsin A丰富的T细胞,胸膜T细胞与外周血液T细胞以及针对各种自身免疫疾病的T细胞.
主要成果:
- 在患有临床显著的irrAEs (AUC = 0.79,p<0.001) 的患者中,T细胞耐受率显著降低 (AUC = 0.79,p<0.001).
- 这种预测值在不同的ICI类型中观察到,尤其是CTLA4抑制剂.
- 耐受性分数在准自身抗原纳素A的T细胞和胸膜T细胞中也较低,这表明与自我耐受性机制的联系.
结论:
- 基线T细胞耐受性分数显示为ICI治疗患者临床显著的irAEs的预测生物标志物.
- 这一新型指标可能有助于识别具有较高IRE风险的患者,并可能指导治疗策略和患者管理.
相关概念视频
Cell-mediated Immune Responses
68.9K
Overview
68.9K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Special Features of Adaptive Immunity
874
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
874


